| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $27.6M | +9.1% |
| Cost of Revenue | $101.8M | +34.5% |
| Gross Profit | $85.8M | +15.4% |
| R&D Expense | $10.5M | -40.2% |
| SG&A Expense | $22.6M | +6.2% |
| Operating Income | -$4.5M | +80.6% |
| Pre-tax Income | $1.2M | +106.5% |
| Income Tax | $94K | -56.9% |
| Net Income | $1.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $76.7M | -38.1% |
| Accounts Receivable | $9.6M | -5.2% |
| Current Assets | $130.2M | -6.9% |
| Total Assets | $138.7M | -2.5% |
| Current Liabilities | $19.0M | -12.1% |
| Total Liabilities | $21.3M | -9.7% |
| Stockholders' Equity | $117.4M | -1.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.7M | +171.4% |
| Investing Cash Flow | -$46.7M | — |
| Financing Cash Flow | -$12.2M | -742.5% |
| +106.0% |
| EPS (Basic) | $0.01 | +108.3% |
| EPS (Diluted) | $0.01 | +108.3% |